Company News

SSE:688687

Kawin Technology Acquires Beijing Certificate of Standardization of Safety in Production

11-022013

In August 2013, Kawin Technology successfully passed a standardization inspection, and acquired the Certificate of Standardization of Safety in Production from Beijing Administration of Work Safety.

Dr. Pan Honored with “Thousand Talents Plan” Kawin Technology Passes the Latest GMP Inspection

Recommended News

02-21

2022

Kawin and HEC Pharm to Jointly ＂Eliminate Hepatitis C＂

On February 14, 2022, Kawin and YiChang HEC ChangJiang Pharmaceutical Co.,Ltd. (hereinafter referred to as HEC Pharm 东阳...

03-20

2020

赛波唯® (Sofosbuvir Tablets) Approved for HCV Treatment

18 March 2020, Kawin Technology's 赛波唯 (Sofosbuvir Tablets) was approved by National Medical Products Administration...

02-12

2020

Class 1 Innovative Drug Coblopasvir Hydrochloride Capsules Launched for Treatment of Hepatitis C Virus

11 February 2020, Kawin Technology's therapeutic drug of chronic hepatitis C virus (HCV) , Coblopasvir Hydrochloride Caps...

03-27

2018

Dr. Zhou Desheng, Chairman of Kawin Technology, Interviewed by Beijing

On March 20th, 2018, Beijing TV Morning Beijing aired a special interview, themed as high-end drug for China and better q...